Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) IPO
IPO
Priced at US$5.00 a share on Jan 19, 2023.
- Price
- US$5.00 a share
- Shares offered
- 3,104,783 shares of common stock · 1,400,000 from the company and 1,704,783 from selling shareholders
- Offering size
- US$7 million
- Underwriters' option
- Up to 210,000 more shares
- Listing
- CVKD on the Nasdaq Capital Market
- Underwriters
- Boustead Securities, LLC, Sutter Securities, Inc., Revere Securities LLC · In the order on the cover
- Shares delivered
- On or about Jan 24, 2023
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 15, 2022 |
| Filed publicly | Sep 22, 2022 |
| Amended 6 times | Newest Jan 17, 2023 |
| Shares registered with an exchange | Jan 17, 2023 |
| Declared effective by the SEC | Jan 19, 2023 |
| Final prospectus, with the price | Jan 23, 2023 |
Filings
From the cover of the final prospectus (424B4) filed Jan 23, 2023